Is frequency of potato and white rice consumption associated with cardiometabolic risk factors in children and adolescents: the CASPIAN-V study.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
19 05 2020
Historique:
received: 17 01 2020
accepted: 12 05 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 1 12 2020
Statut: epublish

Résumé

This study evaluated the association of frequency of potato and rice consumption with cardiometabolic risk factors in children and adolescents. This nationwide cross-sectional survey was conducted on 14,400 children and adolescents. Fasting blood was obtained from a sub-sample of 4200 randomly selected students. Physical examination and laboratory tests were conducted under standard protocols. Metabolic Syndrome (Mets) was defined based on the Adult Treatment Panel III criteria modified for the pediatric age group. The self-reported frequency consumption of white rice and potato was reported on a daily or non-daily basis. The participation rate for the whole study and for blood sampling were 99 and 91.5%, respectively. Overall, 49.4% of the participants were girls while 50.6% were boys. The frequency of daily consumption of white rice and potato was 84.4 and 21.3%, respectively. In the multivariable linear regression model, daily consumption of potato increased body mass index (β: 0.05, SE: 0.20, p = 0.010), waist (β: 0.63, SE: 0.24, p = 0.008), and hip circumferences (β: 0.62, SE: 0.26, p = 0.019). Moreover, in the multivariable logistic regression, daily consumption of potato was significantly associated with an increased risk of overweight (OR: 1.21, 95% CI: 1.04-1.39, P = 0.012). The potato and rice consumption had no statistically significant association with other cardiometabolic risk factors. Daily consumption of potato was significantly associated with higher anthropometric measures, whereas rice consumption had no statistically significant association with cardiometabolic risk factors. Future research to examine the possible obesogenic effects of intake of potato on children and adolescents is recommended.

Sections du résumé

BACKGROUND
This study evaluated the association of frequency of potato and rice consumption with cardiometabolic risk factors in children and adolescents.
METHODS
This nationwide cross-sectional survey was conducted on 14,400 children and adolescents. Fasting blood was obtained from a sub-sample of 4200 randomly selected students. Physical examination and laboratory tests were conducted under standard protocols. Metabolic Syndrome (Mets) was defined based on the Adult Treatment Panel III criteria modified for the pediatric age group. The self-reported frequency consumption of white rice and potato was reported on a daily or non-daily basis.
RESULTS
The participation rate for the whole study and for blood sampling were 99 and 91.5%, respectively. Overall, 49.4% of the participants were girls while 50.6% were boys. The frequency of daily consumption of white rice and potato was 84.4 and 21.3%, respectively. In the multivariable linear regression model, daily consumption of potato increased body mass index (β: 0.05, SE: 0.20, p = 0.010), waist (β: 0.63, SE: 0.24, p = 0.008), and hip circumferences (β: 0.62, SE: 0.26, p = 0.019). Moreover, in the multivariable logistic regression, daily consumption of potato was significantly associated with an increased risk of overweight (OR: 1.21, 95% CI: 1.04-1.39, P = 0.012). The potato and rice consumption had no statistically significant association with other cardiometabolic risk factors.
CONCLUSIONS
Daily consumption of potato was significantly associated with higher anthropometric measures, whereas rice consumption had no statistically significant association with cardiometabolic risk factors. Future research to examine the possible obesogenic effects of intake of potato on children and adolescents is recommended.

Identifiants

pubmed: 32429894
doi: 10.1186/s12872-020-01524-y
pii: 10.1186/s12872-020-01524-y
pmc: PMC7236272
doi:

Substances chimiques

Dietary Carbohydrates 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

239

Références

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2065-71
pubmed: 11742886
Health Rep. 2009 Dec;20(4):11-20
pubmed: 20108602
N Engl J Med. 2011 Jun 23;364(25):2392-404
pubmed: 21696306
PLoS One. 2016 Dec 22;11(12):e0167921
pubmed: 28005914
Eur J Epidemiol. 2013 Nov;28(11):845-58
pubmed: 24158434
Southeast Asian J Trop Med Public Health. 2012 May;43(3):756-63
pubmed: 23077856
J Pediatr (Rio J). 2013 Nov-Dec;89(6):575-82
pubmed: 24029551
Pak J Med Sci. 2015 Jan-Feb;31(1):239-42
pubmed: 25878654
Lancet. 2012 Mar 24;379(9821):1100; author reply 1100-1
pubmed: 22444397
Health Aff (Millwood). 2015 Nov;34(11):1940-8
pubmed: 26526253
Nutr Metab Cardiovasc Dis. 2010 Oct;20(8):599-607
pubmed: 19692216
Br J Nutr. 2007 Aug;98(2):397-405
pubmed: 17391554
J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):480-4
pubmed: 21051005
Obes Res. 2005 Nov;13(11):1952-60
pubmed: 16339127
Am J Clin Nutr. 2010 Oct;92(4):733-40
pubmed: 20685951
Pediatr Gastroenterol Hepatol Nutr. 2014 Jun;17(2):85-92
pubmed: 25061583
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
Eat Weight Disord. 2017 Jun;22(2):321-328
pubmed: 28349369
Am J Clin Nutr. 2007 Aug;86(2):472-9
pubmed: 17684221
Am J Clin Nutr. 2003 Mar;77(3):594-9
pubmed: 12600848
Br J Nutr. 2005 Jun;93(6):923-31
pubmed: 16022763
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Int J Pediatr Endocrinol. 2012 Apr 16;2012(1):6
pubmed: 22507454
Am J Public Health. 2000 Sep;90(9):1409-15
pubmed: 10983198
Am J Clin Nutr. 2002 Aug;76(2):390-8
pubmed: 12145012
Lancet. 2010 May 15;375(9727):1737-48
pubmed: 20451244
Int J Prev Med. 2013 Dec;4(12):1451-60
pubmed: 24498502
Am J Clin Nutr. 2005 Jan;81(1):55-63
pubmed: 15640460
Lancet. 2010 Jan 30;375(9712):408-18
pubmed: 19875164
Diabetes Care. 2004 Feb;27(2):538-46
pubmed: 14747241
Indian J Med Res. 2005 Jan;121(1):23-31
pubmed: 15713975
Int J Prev Med. 2017 Jan 23;8:4
pubmed: 28217266
Eur J Clin Nutr. 2009 Jan;63(1):31-8
pubmed: 17895913
Iran Red Crescent Med J. 2015 Dec 27;17(12):e24723
pubmed: 26756015
Lancet. 2007 Jun 23;369(9579):2059-61
pubmed: 17586288
BMJ. 2016 Jun 14;353:i2716
pubmed: 27301975
Cardiovasc Diabetol. 2009 Jul 18;8:36
pubmed: 19615091
Ann Nutr Metab. 2013;62(3):257-65
pubmed: 23635794
Arch Med Sci. 2014 Feb 24;10(1):96-103
pubmed: 24701221
Nutrients. 2018 Nov 14;10(11):
pubmed: 30441846
Am J Clin Nutr. 2010 Dec;92(6):1468-77
pubmed: 20980490
Clin Chim Acta. 1987 Jun 30;166(1):1-8
pubmed: 3608193
Ann Intern Med. 2010 Aug 3;153(3):147-57
pubmed: 20679559

Auteurs

Fereshteh Baygi (F)

Center of Maritime Health and Society, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark.

Mostafa Qorbani (M)

Non-communicable Diseases Research Center, School of Medicine, Alborz University of Medical Sciences, Baghestan Blvd, Karaj, 31485/56, Iran. mqorbani1379@yahoo.com.
Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. mqorbani1379@yahoo.com.

Mohammad Esmaeil Motlagh (ME)

Department of Pediatrics, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Gita Shafiee (G)

Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Kourosh Nouri (K)

Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran.

Zeinab Ahadi (Z)

Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Armita Mahdavi-Gorab (A)

Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Ramin Heshmat (R)

Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Roya Kelishadi (R)

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH